Need a website? Free website templates by professional designers at WTO.

Kenneth W Yip, PhD




Professor and Scientific Associate






Current Courses:



In The News:



Representative Publications:


Bratman SV, Bruce JP, O'Sullivan B, Pugh TJ, Xu W, Yip KW, Liu FF. Human Papillomavirus genotype association with survival in head and neck squamous cell carcinoma. JAMA Oncol. [Epub ahead of print], 2016.

Spence T, Bruce JP, Yip KW, Liu FF.MicroRNAs in nasopharyngeal carcinoma. Chin Clin Oncol. [Epub ahead of print], 2016.

Kwan JY, Psarianos P, Bruce JP, Yip KW, Liu FF. The complexity of microRNAs in human cancer. J Rad Res. [Epub ahead of print], 2016.
Shi W, Bruce J, Lee M, Yue S, Rowe M, Pintilie M, Kogo R, Bissey PA, Fyles A, Yip KW, Liu FF. MiR-449a promotes breast cancer progression by targeting CRIP2. Oncotarget. [Epub ahead of print], 2016.
Bruce JP, Yip K, Bratman SV, Ito E, Liu FF. Nasopharyngeal cancer: Molecular landscape. J Clin Oncol. 33(29):3346-55, 2015.
Kogo R, How C, Chaudary N, Bruce J, Shi W, Hill RP, Zahedi P, Yip KW, Liu FF. The microRNA-218~survivin axis regualtes migration, invasion, and lymph node metastasis in cervical cancer. Oncotarget. 6(2):1090-100, 2015.
Williams JP, Kim I, Ito E, Shi W, Yue S, Siu LL, Waldron J, O’Sullivan B, Yip KW, Liu FF. Pre-clinical characterization of dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, combined with ionizing radiation for head and neck squamous cell carcinoma. PLoS One. 9(5):e98557, 2014.
Yip KW, Zhang Z, Sakemura-Nakatsugawa N, Huang JW, Vu NM, Chiang YK, Lin Cl, Kwan JYY, Yue S, Jitkova Y, To T, Zahedi P, Pai EF, Schimmer AD, Lovell JF, Sessler JL, Liu FF. A Porphodimethene Chemical Inhibitor of Uroporphyrinogen Decarboxylase. PLOS ONE. 9(2):e89889, 2014.
Ito E, Yue S, Moriyama E, Kim I, Hui A, Shi W, Alajez N, Bhogal N, Li GH, Datti A, Schimmer A, Liu P, Durocher D, Neel B, O’Sullivan B, Cummings B, Bristow R, Liu FF. Uroporphyrinogen decarboxylase is a radiosensitizing target for head and neck cancer. Science Translational Medicine. 3:67ra7, 2011.
Ito E, Yip KW, Katz D, Hedley DW, Chow S, Xu W, Wood TE, Bastianutto C, Schimmer AD, Liu FF. Potential use of cetrimonium bromide as an apoptosis-promoting anticancer agent for head and neck cancer. Mol Pharmacol. 76(5):969-983, 2009.